Published in Int J Tuberc Lung Dis on November 01, 2004
Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med (2008) 6.17
Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis (2006) 3.32
Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One (2009) 2.47
What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One (2013) 2.05
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis (Edinb) (2012) 1.87
Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PLoS One (2011) 1.79
Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India. PLoS One (2012) 1.69
Randomized trials to optimize treatment of multidrug-resistant tuberculosis. PLoS Med (2007) 1.46
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India. Indian J Med Res (2011) 1.46
Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study. PLoS One (2015) 1.37
Principles for designing future regimens for multidrug-resistant tuberculosis. Bull World Health Organ (2013) 1.17
Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006. PLoS One (2009) 1.16
Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med (2008) 1.15
Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear Nose Throat Disord (2007) 1.13
Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health Organ (2007) 1.12
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa. PLoS One (2013) 1.12
Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania. PLoS One (2013) 1.06
Prevalence of hypothyroidism among MDR-TB patients in Botswana. Int J Tuberc Lung Dis (2012) 1.02
The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia. South Med Rev (2012) 0.99
Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2013) 0.97
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients. PLoS One (2013) 0.96
Epidemiology and treatment of multidrug resistant tuberculosis. Semin Respir Crit Care Med (2008) 0.96
Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review. PLoS Med (2012) 0.95
Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst Synth Biol (2011) 0.94
Drug-resistant tuberculosis in the WHO Western Pacific Region. Western Pac Surveill Response J (2014) 0.93
Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005. Int J Tuberc Lung Dis (2012) 0.91
Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico. Tuberc Res Treat (2011) 0.87
Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection. Antimicrob Agents Chemother (2006) 0.84
Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan. Saudi Med J (2015) 0.81
Preventing nosocomial MDR TB transmission in sub Saharan Africa: where are we at? Glob J Health Sci (2013) 0.81
Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success. PLoS One (2015) 0.78
Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward. Public Health Action (2014) 0.78
Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment. PLoS Med (2014) 0.78
TSH-CHECK-1 test: diagnostic accuracy and potential application to initiating treatment for hypothyroidism in patients on anti-tuberculosis drugs. PLoS One (2012) 0.78
Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam. BMC Res Notes (2015) 0.75
Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies. Infect Dis Poverty (2017) 0.75
[Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin]. Rev Peru Med Exp Salud Publica (2013) 0.75
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia. Patient Prefer Adherence (2016) 0.75
First use of bedaquiline in a patient with XDR-TB in Singapore. BMJ Case Rep (2015) 0.75
The phylogeny of prokaryotes. Science (1980) 24.57
Detailed analysis of the higher-order structure of 16S-like ribosomal ribonucleic acids. Microbiol Rev (1983) 23.08
Timing the ancestor of the HIV-1 pandemic strains. Science (2000) 10.42
Secondary structure model for bacterial 16S ribosomal RNA: phylogenetic, enzymatic and chemical evidence. Nucleic Acids Res (1980) 9.50
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Secondary structure model for 23S ribosomal RNA. Nucleic Acids Res (1981) 7.12
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83
Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bull World Health Organ (2001) 6.07
Sequence of the 16S Ribosomal RNA from Halobacterium volcanii, an Archaebacterium. Science (1983) 5.66
Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India (2009) 5.45
The phylogeny of purple bacteria: the alpha subdivision. Syst Appl Microbiol (1984) 4.96
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2005) 4.57
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ (2001) 4.15
Were the original eubacteria thermophiles? Syst Appl Microbiol (1987) 4.06
Mianserin hydrochloride: a novel antidepressant. Br J Psychiatry (1976) 3.92
Rooting the archaebacterial tree: the pivotal role of Thermococcus celer in archaebacterial evolution. Syst Appl Microbiol (1988) 3.76
Factors affecting uptake of antenatal HIV testing in London: results of a multicentre study. BMJ (1998) 3.72
Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ (2009) 3.62
Putative introns in tRNA genes of prokaryotes. Proc Natl Acad Sci U S A (1983) 3.60
Analgesic efficacy of pre-operative stellate ganglion block on postoperative pain relief: a randomised controlled trial. Anaesthesia (2014) 3.30
Halobacterium volcanii tRNAs. Identification of 41 tRNAs covering all amino acids, and the sequences of 33 class I tRNAs. J Biol Chem (1984) 3.25
Sequence of the 16S rRNA gene from the thermoacidophilic archaebacterium Sulfolobus solfataricus and its evolutionary implications. J Mol Evol (1985) 3.20
Public health. Responding to market failures in tuberculosis control. Science (2001) 3.12
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis (2000) 2.87
Structural basis for the recognition of DNA repair proteins UNG2, XPA, and RAD52 by replication factor RPA. Cell (2000) 2.73
Prediction of human protein function according to Gene Ontology categories. Bioinformatics (2003) 2.54
Transcription and excision of a large intron in the tRNATrp gene of an archaebacterium, Halobacterium volcanii. J Biol Chem (1985) 2.45
Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol Cell Biol (1995) 2.44
Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet (1998) 2.34
Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr Biol (1997) 2.24
The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis (2001) 2.23
Blood pressure cuffs: friend or foe? J Hosp Infect (2006) 2.15
Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut (2007) 2.11
Lymphatic manifestations of lymphangioleiomyomatosis. Lymphology (2014) 2.06
With a pinch of salt. Clin Med (2010) 2.06
Prediction of human protein function from post-translational modifications and localization features. J Mol Biol (2002) 2.05
Surgical decisions in the elderly: the importance of biological age. J R Soc Med (2001) 2.02
Novel protein kinases associated with calcineurin B-like calcium sensors in Arabidopsis. Plant Cell (1999) 2.02
Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India (2001) 2.01
Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis (2007) 1.96
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis (2006) 1.94
Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Int J Tuberc Lung Dis (2001) 1.85
The pleckstrin homology domain of phospholipase C-delta 1 binds with high affinity to phosphatidylinositol 4,5-bisphosphate in bilayer membranes. Biochemistry (1995) 1.84
Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology (2008) 1.80
Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis (2001) 1.80
Recombination activities of HsDmc1 protein, the meiotic human homolog of RecA protein. Proc Natl Acad Sci U S A (1997) 1.79
Will tuberculosis become resistant to all antibiotics? Proc Biol Sci (2001) 1.79
The phylogenetic relationships of three sulfur dependent archaebacteria. Syst Appl Microbiol (1984) 1.79
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin Infect Dis (2000) 1.72
Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond) (2006) 1.71
Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol (2001) 1.71
Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res (2001) 1.70
Multiple retinal haemorrhages (decompression retinopathy) following paracentesis for macular branch artery occlusion. Eye (Lond) (2005) 1.70
Treatment of uncomplicated gonorrhoea in women. Comparison of rosoxacin and spectinomycin. Br J Vener Dis (1982) 1.69
Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg (1993) 1.69
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1996) 1.68
Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuberc Lung Dis (2004) 1.67
Prevalence of tobacco use and awareness of risks among school children in Jaipur. J Assoc Physicians India (2006) 1.66
Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest (2001) 1.66
Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology (1992) 1.66
Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial. Crit Care Med (1998) 1.65
Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology (2008) 1.60
Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004. Int J Tuberc Lung Dis (2010) 1.60
The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers. Carcinogenesis (1998) 1.59
Posttranscriptional modification of tRNA in thermophilic archaea (Archaebacteria). J Bacteriol (1991) 1.57
Mouse B7-H3 induces antitumor immunity. Gene Ther (2003) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
The burden of drug-resistant tuberculosis and mechanisms for its control. Ann N Y Acad Sci (2001) 1.55
Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology (2004) 1.55
Ascitic fluid cholesterol in malignant and tubercular ascites. J Assoc Physicians India (1995) 1.54
Interaction specificity of Arabidopsis calcineurin B-like calcium sensors and their target kinases. Plant Physiol (2000) 1.53
Structure of a modified nucleoside in archaebacterial tRNA which replaces ribosylthymine. 1-Methylpseudouridine. J Biol Chem (1982) 1.51
ATMPK4, an Arabidopsis homolog of mitogen-activated protein kinase, is activated in vitro by AtMEK1 through threonine phosphorylation. Plant Physiol (2000) 1.46
Psoas abscess - not as rare as we think? Colorectal Dis (2007) 1.45
Role of recombinant human erythropoietin in patients of advanced cervical cancer treated "by chemoradiotherapy". Cancer Biol Ther (2009) 1.44
Quantitative food frequency questionnaire and assessment of dietary intake. Natl Med J India (1999) 1.44
Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guérin (Danish 1331 strain). BJU Int (2002) 1.44
The social determinants of health: key to global tuberculosis control. Int J Tuberc Lung Dis (2011) 1.44
Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens (2012) 1.43
Comparison between low and high pressure suction drainage following axillary clearance. Eur J Surg Oncol (2000) 1.43
Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J (2001) 1.42
Diabetes and heat shock protein. Nature (1992) 1.40
Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis (1994) 1.39
Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med (2010) 1.39
Life-threatening diarrhea after short-term misoprostol use in a patient with Crohn ileocolitis. Ann Intern Med (1990) 1.39
Precipitation of acute intermittent porphyria by chloroquin. Indian Pediatr (1996) 1.39
Autoinoculation lupus vulgaris of the perineum. Genitourin Med (1991) 1.39
Inferior venacaval obstruction following burns. J Assoc Physicians India (1990) 1.39
A method to facilitate nasoenteral feeding tube placement. Anaesth Intensive Care (2005) 1.39
Failure of praziquantel and albendazole in neurocysticercosis. J Assoc Physicians India (1990) 1.39
Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39
Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. Prostate (2005) 1.38
Cataract aspiration-irrigation. Modified needle-tubing-handle combination for push-pull machine. Br J Ophthalmol (1975) 1.38
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut (2002) 1.38
Molecular characterization of a tyrosine-specific protein phosphatase encoded by a stress-responsive gene in Arabidopsis. Plant Cell (1998) 1.36
Acute superior mesenteric ischaemia. Br J Surg (1987) 1.35